The Association of Resilience with Psychiatric Morbidity, Sleep Quality and Antiretroviral Therapy Adherence among Older Adults Living with HIV in Nigeria
Authors:
- Olufisayo Oluyinka ElugbadeboOEOlufisayo Oluyinka Elugbadebo
- Lisa M. KuhnsLKLisa M. Kuhns
- Lauren Brittany BeachLBLauren Brittany Beach
- Bibilola D. OladejiBOBibilola D. Oladeji
- Chiamaka EgbunaCEChiamaka Egbuna
- Olutosin AwoludeOAOlutosin Awolude
- Olayinka OmigbodunOOOlayinka Omigbodun
- Philip B. GorelickPGPhilip B. Gorelick
Preprint
- 8 October 2026
- preprint
- Published by Springer Nature in Research Square
Abstract
Advances in antiretroviral therapy (ART) have increased survival among people living with HIV, resulting in a growing population of older adults who often face persistent psychological challenges. However, limited evidence exists on how in the face of these challenges, resilience may interact with psychiatric morbidity and HIV treatment adherence in African countries. This study therefore examined resilience among older adults living with HIV in Ibadan, Nigeria and its association with psychiatric morbidity and ART adherence. In this cross-sectional study, resilience, psychiatric morbidity and HIV treatment adherence were assessed among 400 older adults aged ≥ 50 years living with HIV. Resilience, depression, anxiety and sleep quality were measured using the 25-item Wagnild and Young resilience scale, Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder 7-item scale (GAD-7) and the Pittsburgh Sleep Quality Index (PSQI) respectively. Antiretroviral medication adherence was self-reported for the prior 30-days. Associations between resilience levels, psychiatric morbidity, and medication adherence outcomes were investigated using multivariable logistic regression controlling for demographic and clinical factors. The mean age of participants was 58.2 ± 6.5 years. Low resilience was common, affecting approximately 89.7% of the cohort. The prevalence of psychiatric morbidity was 7.8% for depression, 6.0% for anxiety, and 15.2% for poor sleep quality. Overall, ART adherence was relatively high, with 85.5% of participants reporting adequate adherence. Higher resilience scores were associated with lower odds of depression (adjusted [aOR] = 0.958, 95% CI: 0.939–0.977), anxiety (aOR = 0.971, 95% CI: 0.950–0.993, p = 0.010) and an increased odds of at least 95% antiretroviral therapy adherence (aOR = 1.033, 95% CI: 1.008–1.058, p = 0.009). In this study of older adults living with HIV in Nigeria, the level of resilience was low but was protective for psychiatric morbidity and medication adherence. Promoting resilience may improve well-being among aging populations living with HIV.Keywords
All Related Versions
Funding Information
- Fogarty International Center (D43TW009608.)
This publication has 41 references indexed in Scilit:
- Sociodemographic and HIV-Related Characteristics Associated with Mental Health Diagnoses Among People Living with HIVAIDS and Behavior, 2026
- Resilience, and Personality Traits as Independent Correlates of Perceived Treatment Management Abilities in Middle-Aged and Older People Living with HIVAIDS and Behavior, 2025
- Aging With HIV in Nigeria: A Narrative Review of Multimorbidity and Healthcare Access ChallengesHealth Science Reports, 2025
- Health Outcomes Associated with Loneliness and Social Isolation in Older Adults Living with HIV: A Systematic ReviewAIDS and Behavior, 2024
- Investigating state and trait aspects of resilience using Generalizability theoryCurrent Psychology, 2023
- Comparison of Antiretroviral Therapy Adherence Among HIV-Infected Older Adults with Younger Adults in Africa: Systematic Review and Meta-analysisAIDS and Behavior, 2018
- Resilience and Physical and Mental Well-Being in Adults with and Without HIVAIDS and Behavior, 2017
- Resilience Moderates the Association Between Childhood Sexual Abuse and Depressive Symptoms Among Women with and At-Risk for HIVAIDS and Behavior, 2014
- Aging, Antiretrovirals, and Adherence: A Meta Analysis of Adherence among Older HIV-Infected IndividualsDrugs & Aging, 2013
- Development of a new resilience scale: The Connor-Davidson Resilience Scale (CD-RISC)Depression and Anxiety, 2003